Mario A. Dicato – författare

Nausea and vomiting are two of the most common side-effects of anti-cancer treatment, and the discovery and clinical application of 5-hydroxytryptamine3 receptor antagonists has transformed the management of these side effects, resulting in a much improved quality of life for cancer patients. This text presents a detailed overview of the management of cancer-treatment induced emesis in a number of different treatment settings, and focuses on the mechanisms and use of 5-HT3 receptor antagonists. Contributions are also included from the points of view of the nurse and the patient.

This is the second edition of a well-received book that reflects the state of the art in cancer medical therapies and their side-effects, including immunotherapy and chemotherapeutic drugs. All chapters have been fully updated to include all the latest progress in drug discovery such as targeted therapies for each cancer type.

The third edition of this book has been extensively expanded to discuss all aspects of cancer treatment side-effects in everyday life, covering a range of issues from skin problems to fertility problems, Divided in three major parts, the first part covers medical cancer therapy side effects, ranging from organ-related toxicities to drug group particularities. In the second part the adverse events in surgery are extensively discussed, covering issues in regular and robotic surgery and discussing indications and effectiveness. Finally, in the third part, the balance of efficacy versus toxicity in radiotherapy is discussed for different tumor types. The reader will learn about the state of the art in cancer therapies and their side-effects as well as possible prevention. Chapters remain up to date via electronic updates and include all the latest progress in drug discovery, surgery and radiotherapy. This is a very comprehensive work written by a team of world experts and edited by key opinion leaders. This book is aimed at medical, surgical and clinical  oncologists but is a great resource for junior doctors, trainees, pharmacists and nurses.